This inventor holds 1 USPTO granted patent. Top assignee: Chdi Foundation, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Cole Clissold: A Glimpse into His Contributions to Huntington's Disease Treatment
Introduction
Cole Clissold, an inventor based in Saffron Walden, United Kingdom, has made significant strides in the field of medical innovations. With a keen focus on addressing complex neurological conditions, his work has centered on providing viable solutions for Huntington's disease.
Latest Patents
Cole holds a notable patent for HTT modulators aimed at treating Huntington's disease. This patent describes certain compounds that act as effective HTT modulators, which are beneficial in the treatment of this challenging condition. Such innovations represent a noteworthy advancement in therapeutic options for affected individuals.
Career Highlights
Currently, Clissold is affiliated with the Chdi Foundation, Inc., where he continues to contribute to groundbreaking research and development in the medical field. His dedication to addressing Huntington's disease through innovative strategies underscores his commitment to improving patient outcomes.
Collaborations
Throughout his career, Cole has worked alongside esteemed colleagues, including Longbin Liu and Celia Dominguez. Collaborating with experts in their respective fields has allowed for a rich exchange of ideas and methodologies, enhancing the potential impact of their combined work.
Conclusion
Cole Clissold's contributions to the field of medicine, particularly concerning Huntington's disease, demonstrate his innovative spirit and dedication to improving lives. With his patent on HTT modulators, he is paving the way for the next generation of treatments. As he continues his work at the Chdi Foundation, there is great anticipation for what further innovations he will bring forth in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
